You are here

Spark Therapeutics

Roche, Spark push back takeover deadline in $4.3 billion deal

Roche, Spark push back takeover deadline in $4.3 billion deal

Yahoo/Reuters

Spark Therapeutics

Flag link:

Sangamo backs up early success for hemophilia gene therapy

Sangamo backs up early success for hemophilia gene therapy

Biopharma Dive

Spark Therapeutics

Flag link:

The top 10 most-expensive meds in the U.S.—and they're not the usual suspects

The top 10 most-expensive meds in the U.S.—and they're not the usual suspects

Fierce Pharma

Spark Therapeutics

Flag link:

FTC demands could mean months-long delay for Roche-Spark deal

FTC demands could mean months-long delay for Roche-Spark deal

Biopharma Dive

Spark Therapeutics

Flag link:

Investors fret as new regulatory probes spur fresh delays to Roche's $4.3B Spark buyout

Investors fret as new regulatory probes spur fresh delays to Roche's $4.3B Spark buyout

Endpoints

Spark Therapeutics

Flag link:

What's taking the FTC so long? Roche won't say, but insists it will bag Spark on time — despite third delay

What's taking the FTC so long? Roche won't say, but insists it will bag Spark on time — despite third delay

Endpoints

Spark Therapeutics

Flag link:

Roche delays $4.3B Spark buyout — again — as FTC review drags on

Roche delays $4.3B Spark buyout — again — as FTC review drags on

Endpoints

Spark Therapeutics

Flag link:

Roche must ask Spark shareholders once again to sell

Roche must ask Spark shareholders once again to sell

Biopharma Dive

Spark Therapeutics

Flag link:

Gene therapy progress spurs competition in biotech buyouts

Gene therapy progress spurs competition in biotech buyouts

Biopharma Dive

Nightstar Therapeutics

Spark Therapeutics

Flag link:

Spark bidding war drove Roche bid up by $2.1 billion

Spark bidding war drove Roche bid up by $2.1 billion

BioCentury

Spark Therapeutics

Flag link:

Roche Bets $4.8B on Spark Therapeutics and the Future of Gene Therapy

Roche Bets $4.8B on Spark Therapeutics and the Future of Gene Therapy

Xconomy

Spark Therapeutics

Flag link:

This Gene Therapy Stock Could Soon Hit The Auction Block — Here's Why

This Gene Therapy Stock Could Soon Hit The Auction Block — Here's Why

Investors Business Daily

Spark Therapeutics

Flag link:

Uniqure turns the screw on Spark and Pfizer

Uniqure turns the screw on Spark and Pfizer

EP Vantage

Spark Therapeutics

Flag link:

JPM19: Spark looks at scale, manufacturing as gene therapy matures

JPM19: Spark looks at scale, manufacturing as gene therapy matures

Biopharma Dive

Spark Therapeutics

Flag link:

2 Sets of Disasters Biotech Will Pay For in 2019

2 Sets of Disasters Biotech Will Pay For in 2019

Yahoo/Motley Fool

Gilead Sciences

Spark Therapeutics

Flag link:

Luxturna cleared for sale in Europe, but payer support uncertain

Luxturna cleared for sale in Europe, but payer support uncertain

Biopharma Dive

Spark Therapeutics

Flag link:

Novartis/Spark’s sight gene therapy approved in EU

Novartis/Spark’s sight gene therapy approved in EU

Pharmaforum

Spark Therapeutics

Flag link:

Spark's CSO is wrapping up animal studies on a gene therapy for Pompe disease as new work in the field sees explosive growth

Spark's CSO is wrapping up animal studies on a gene therapy for Pompe disease as new work in the field sees explosive growth

Endpoints

Spark Therapeutics

Flag link:

Spark/Novartis eye gene therapy nears EU market – but at what price?

Spark/Novartis eye gene therapy nears EU market – but at what price?

Pharmaforum

Spark Therapeutics

Flag link:

Express Scripts staking out million-dollar gene therapies

Express Scripts staking out million-dollar gene therapies

Reuters

Express Scripts

Spark Therapeutics

Flag link:

Pages